Tioga Pharmaceuticals Tioga Pharmaceuticals is a company that provides a therapy for the treatment of pruritus. | ![]() Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | ![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ![]() Melinta Therapeutics Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
| Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. | |
Founding Date | Founding Date 2005 | Founding Date 1983 | Founding Date 2012 | Founding Date 2000 | Founding Date 1990 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations San Diego, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Morristown, US HQ New Haven, US | Locations Rehovot, IL HQ Beit Kama, IL |
Employees | Employees 4 | Employees 20333% decrease | Employees 352106% increase | Employees 1712% increase | Employees 420 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 268.5 m | Valuation ($) 4.4 b | Valuation ($) N/A | Valuation ($) 317 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $180.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $41.3m (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods N/A | Cost of goods $72.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $113.6m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $108.4m (FY, 2025) |
Net income | Net income N/A | Net income ($20.2m) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income N/A | Net income $20.2m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised $ 519.2m | Total funding raised $ 90m |

Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
View companyKamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View company